These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 32533250)

  • 1. Multifocal osteolytic lesions in hairy cell leukemia-the importance of PET/CT in diagnosis and assessment.
    Robak P; Jesionek-Kupnicka D; Kupnicki P; Polliack A; Robak T
    Ann Hematol; 2021 Jun; 100(6):1641-1645. PubMed ID: 32533250
    [No Abstract]   [Full Text] [Related]  

  • 2. Bone lesions in hairy cell leukemia: Diagnosis and treatment.
    Robak P; Jesionek-Kupnicka D; Kupnicki P; Polliack A; Robak T
    Eur J Haematol; 2020 Dec; 105(6):682-691. PubMed ID: 32757401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skeletal involvement in hairy cell leukemia.
    Herold CJ; Wittich GR; Schwarzinger I; Haller J; Chott A; Mostbeck G; Hajek PC
    Skeletal Radiol; 1988; 17(3):171-5. PubMed ID: 3375842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical relevance of 18F-FDG-negative osteoblastic metastatic bone lesions noted on PET/CT in breast cancer patients.
    Al-Muqbel KM; Yaghan RJ; Al-Omari MH; Rousan LA; Dagher NM; Al Bashir S
    Nucl Med Commun; 2016 Jun; 37(6):593-601. PubMed ID: 26813990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone involvement in hairy cell leukemia.
    Quesada JR; Keating MJ; Libshitz HI; Llamas L
    Am J Med; 1983 Feb; 74(2):228-31. PubMed ID: 6824003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-FDG PET/CT for Staging and Evaluation of Therapy in a Patient With Unusual Hairy Cell Leukemia Presentation.
    Doma A; Škerget M; Žagar I
    Clin Nucl Med; 2019 Jul; 44(7):e458-e460. PubMed ID: 30985440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of ex vivo micro-computed tomography for assessment of in vivo fluorescence and plain radiographic imaging for monitoring bone metastases and osteolytic lesions.
    Tiwari S; Schem C; Lorenzen AC; Kayser O; Wiese C; Graeff C; Peña J; Marshall RP; Heller M; Kalthoff H; Jonat W; Glüer CC
    J Bone Miner Metab; 2012 May; 30(3):373-80. PubMed ID: 22130787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paraproteinaemia plus osteolytic lesions in typical hairy-cell leukaemia.
    Jansen J; Bolhuis RL; van Nieuwkoop JA; Schuit HR; Kroese WF
    Br J Haematol; 1983 Aug; 54(4):531-41. PubMed ID: 6347241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteolytic and osteoblastic metastases due to carcinoid tumors.
    Manoli RS; Barthelemy CR
    Clin Nucl Med; 1980 Mar; 5(3):102-5. PubMed ID: 7357764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hairy-cell leukemia presenting as lytic bone lesions.
    Gray MT; Rutherford MN; Bonin DM; Patterson B; Lopez PG
    J Clin Oncol; 2013 Sep; 31(25):e410-2. PubMed ID: 23797001
    [No Abstract]   [Full Text] [Related]  

  • 11. Hairy Cell Leukemia and Bone Pain.
    Streu E
    Oncol Nurs Forum; 2016 Jan; 43(1):18-21. PubMed ID: 26679440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interesting appearance of osseous hemangioma of the calcaneus on bone scintigraphy: correlative imaging with radiography CT and MRI.
    Hod N; Ashkenazi I; Cohen I; Somekh M; Bickels J
    Clin Nucl Med; 2006 Jul; 31(7):420-2. PubMed ID: 16785815
    [No Abstract]   [Full Text] [Related]  

  • 13. Unusual presentation of hairy cell leukemia.
    Spedini P; Tajana M; Bergonzi C
    Haematologica; 2000 May; 85(5):548. PubMed ID: 10800175
    [No Abstract]   [Full Text] [Related]  

  • 14. Osteoradionecrosis after three-dimensional conformal radiotherapy for recurrent cervical cancer presenting as a progressive osteolytic lesion.
    Lee JA; Huh SJ; Oh D; Bae DS
    Ann Nucl Med; 2008 Feb; 22(2):139-41. PubMed ID: 18311539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ¹⁸F-FDG PET/CT imaging in blow-out metastases of clavicle from carcinoma of urinary bladder.
    Mukherjee A; Karunanithi S; Singla S; Agarwal KK; Kumar A; Kumar R
    Rev Esp Med Nucl Imagen Mol; 2015; 34(2):136-8. PubMed ID: 25444393
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment options in skeletal localizations of hairy cell leukemia: a systematic review on the role of radiation therapy.
    Filippi AR; Franco P; Marinone C; Tarella C; Ricardi U
    Am J Hematol; 2007 Nov; 82(11):1017-21. PubMed ID: 17654508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone lesions in hairy cell leukemia. A case report and response of bone pains to steroids.
    Arkel YS; Lake-Lewin D; Savopoulos AA; Berman E
    Cancer; 1984 Jun; 53(11):2401-3. PubMed ID: 6201258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skeletal complications in hairy cell leukemia: diagnosis and therapy.
    Lembersky BC; Ratain MJ; Golomb HM
    J Clin Oncol; 1988 Aug; 6(8):1280-4. PubMed ID: 3411340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and (99m)Tc-MDP whole-body bone scanning for imaging osteolytic bone metastases.
    Zhang L; Chen L; Xie Q; Zhang Y; Cheng L; Li H; Wang J
    BMC Med Imaging; 2015 Mar; 15():7. PubMed ID: 25885599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hairy cell leukemia and myelomatosis: chance association or clinical manifestations of the same B-cell disease spectrum.
    Catovesky D; Costello C; Loukopoulos D; Fessas PR; Foxley JM; Traub NE; Mills MJ; O'Brien M
    Blood; 1981 Apr; 57(4):758-63. PubMed ID: 6970599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.